Eribulin mesylate in the treatment of metastatic breast cancer
Sarika Jain, Tessa CiglerDepartment of Medicine, Weill Cornell Medical College, New York, NY, USAAbstract: The treatment of metastatic breast cancer (MBC) has become increasingly challenging as the primary goals of therapy include prolonging life without added toxicity. While multiple agents are app...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e4b6daa81e6f4cc294aa1d0945c94463 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|